Ken Griffin Teleflex Inc Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$215.39 - $255.05 $107,695 - $127,525	-500 Reduced 5.81%	8,100 $1.83 Million
Q4 2023 Feb 14, 2024	BUY	$179.39 - $256.21 $287,024 - $409,935	1,600 Added 22.86%	8,600 $2.14 Million
Q3 2023 Nov 14, 2023	BUY	$196.41 - $258.77 $373,179 - $491,662	1,900 Added 37.25%	7,000 $1.37 Million
Q2 2023 Aug 14, 2023	SELL	$232.06 - $274.11 $3.71 Million - $4.39 Million	-16,000 Reduced 75.83%	5,100 $1.23 Million
Q1 2023 May 15, 2023	SELL	$222.88 - $262.22 $6.78 Million - $7.97 Million	-30,400 Reduced 59.03%	21,100 $5.34 Million

Q4 2022 Feb 14, 2023	BUY	$188.57 - $253.75 $4.73 Million - $6.37 Million	25,100 Added 95.08%	51,500 $12.9 Million
Q3 2022 Nov 14, 2022	SELL	$201.46 - $267.32 $1.73 Million - $2.3 Million	-8,600 Reduced 24.57%	26,400 $5.32 Million

511

45.8M

23.9K

38.7K

Ticker TFX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,906,400
Market Cap $9.91B
Description
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.